Publicaciones (35) Publicaciones en las que ha participado algún/a investigador/a

2012

  1. A combined analysis of microarray gene expression studies of the human prefrontal cortex identifies genes implicated in schizophrenia

    Journal of Psychiatric Research, Vol. 46, Núm. 11, pp. 1464-1474

  2. Altered pallido-pallidal synaptic transmission leads to aberrant firing of globus pallidus neurons in a rat model of Parkinson's disease

    Journal of Physiology, Vol. 590, Núm. 22, pp. 5861-5875

  3. Cellular neurochemical characterization and subcellular localization of phospholipase C β1 in rat brain

    Neuroscience, Vol. 222, pp. 239-268

  4. Crosstalk between cdk5 and MEK-ERK signalling upon opioid receptor stimulation leads to upregulation of activator p25 and MEK1 inhibition in rat brain

    Neuroscience, Vol. 215, pp. 17-30

  5. Differential regulation of RGS proteins in the prefrontal cortex of short- and long-term human opiate abusers

    Neuropharmacology, Vol. 62, Núm. 2, pp. 1044-1051

  6. EBI2 regulates CXCL13-mediated responses by heterodimerization with CXCR5

    FASEB Journal, Vol. 26, Núm. 12, pp. 4841-4854

  7. Effect of synthetic cannabinoid CB1 agonist (WIN 55212-2) and antagonist (AM 251) on intraocular pressure in rats

    Glaucoma: Etiology, Pathogenesis and Treatments (Nova Science Publishers, Inc.), pp. 147-156

  8. Endocannabinoid modulation of dopaminergic motor circuits

    Frontiers in Pharmacology, Vol. 3 JUN

  9. Endomorphin-2: A biased agonist at the μ-opioid receptor

    Molecular Pharmacology, Vol. 82, Núm. 2, pp. 178-188

  10. Enhancement of μ-opioid receptor desensitization by nitric oxide in rat locus coeruleus neurons: Involvement of reactive oxygen species

    Journal of Pharmacology and Experimental Therapeutics, Vol. 342, Núm. 2, pp. 552-560

  11. Erratum: What does CNTNAP2 reveal about autism spectrum disorder?. [Trends in Molecular Medicine 18 (2012), 156-163].

    Trends in Molecular Medicine

  12. HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity

    Nature Neuroscience, Vol. 15, Núm. 9, pp. 1245-1254

  13. Hypocretin/orexin signaling in the hypothalamic paraventricular nucleus is essential for the expression of nicotine withdrawal

    Biological Psychiatry, Vol. 71, Núm. 3, pp. 214-223

  14. Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A·mGlu2) receptor heteromerization and its psychoactive behavioral function

    Journal of Biological Chemistry, Vol. 287, Núm. 53, pp. 44301-44319

  15. Influence of δ-opioid receptors in the behavioral effects of nicotine

    Neuropsychopharmacology, Vol. 37, Núm. 10, pp. 2332-2344

  16. Long lasting effects of early-life stress on glutamatergic/GABAergic circuitry in the rat hippocampus

    Neuropharmacology, Vol. 62, Núm. 5-6, pp. 1944-1953

  17. Modulation of neurotransmitter release in orexin/hypocretin-2 receptor knockout mice: A microdialysis study

    Journal of Neuroscience Research, Vol. 90, Núm. 3, pp. 588-596

  18. Neurological soft signs in patients with psychosis and cannabis abuse: a systematic review and meta-analysis of paradox.

    Current pharmaceutical design, Vol. 18, Núm. 32, pp. 5156-5164

  19. Partially hydrolyzed guar gums reduce dietary fatty acid and sterol absorption in guinea pigs independent of viscosity

    Lipids, Vol. 47, Núm. 7, pp. 697-705

  20. Plasma antioxidant capacity is reduced in Asperger syndrome

    Journal of Psychiatric Research, Vol. 46, Núm. 3, pp. 394-401